Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-23-048195
Filing Date
2023-09-14
Accepted
2023-09-14 16:30:13
Documents
1
Period of Report
2023-09-13

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4168
  Complete submission text file 0000950170-23-048195.txt   5583
Mailing Address 524 BROADWAY NEW YORK NY 10013
Business Address WALLSTRASSE 16 BERLIN 2M 10179 (617)-699-5876
ATAI Life Sciences N.V. (Issuer) CIK: 0001840904 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ATAI LIFE SCIENCES N.V. 180 VARICK STREET NEW YORK NY 10014
Business Address
Brand Florian (Reporting) CIK: 0001860682 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40493 | Film No.: 231255437